Xenon Pharmaceuticals Inc

(NASDAQ:XENE)

Latest On Xenon Pharmaceuticals Inc (XENE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsXenon Pharmaceuticals: Navigating The Neural Network Of Epilepsy And DepressionN/A
2023-05-13 22:20 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 20:01 ESTNewsXenon Pharma GAAP EPS of -$0.63 beats by $0.01N/A
2023-05-09 05:53 ESTNewsXenon Pharma Q1 2023 Earnings PreviewN/A
2023-03-15 18:51 ESTNewsXenon May Have A Surprise In Store For Major Depressive DisorderN/A
2023-03-02 08:45 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 18:23 ESTNewsXenon Pharma GAAP EPS of -$0.57 beats by $0.02N/A
2023-03-01 03:05 ESTNewsXenon Pharma Q4 2022 Earnings PreviewN/A
2023-02-08 14:29 ESTNewsXenon Pharmaceuticals: De-Risked Late-Stage Neurology Biotech, BuyN/A
2022-12-23 16:03 ESTNewsXenon Pharmaceuticals: Momentum Still Accelerating, Rate Buy (Technical Analysis)N/A
2022-11-28 20:23 ESTNewsXenon initiated Overweight at Wells Fargo on prospects in depressionN/A
2022-11-08 21:25 ESTNewsXenon Pharma GAAP EPS of -$0.57 misses by $0.05, revenue of $0.13M misses by $2.89MN/A
2022-11-08 21:24 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q3 2022 Earnings Call TranscriptN/A
2022-10-19 16:36 ESTNewsXenon started at outperform at Raymond James on experimental epilepsy drugN/A
2022-09-06 17:12 ESTNewsPutting Xenon Pharmaceuticals Back In The SpotlightN/A
2022-08-29 20:33 ESTNewsXenon initiated with Buy at BofA citing potential of anti-seizure drugN/A
2022-08-11 01:42 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 07:40 ESTNewsXenon Pharma GAAP EPS of -$0.55 misses by $0.06, revenue of $0.54M misses by $2.71MN/A
2022-08-09 11:57 ESTNewsXenon Pharma Q2 2022 Earnings PreviewN/A
2022-07-22 07:20 ESTNewsXenon added to JP Morgan’s analyst focus list citing lead assetN/A
2022-06-23 22:26 ESTNewsXenon Pharmaceuticals slides on pricing $250M equity offeringN/A
2022-06-23 22:26 ESTNewsHot Stocks: OXY rises as Buffett adds shares, SNOW pops on upgrade, KBH also gains and XENE declinesN/A
2022-06-23 03:58 ESTNewsXenon slips 11% on public offering of common stockN/A
2022-05-11 12:48 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 17:11 ESTNewsXenon Pharma GAAP EPS of -$0.35 beats by $0.07, revenue of $8.77M beats by $1.03MN/A
2022-05-09 19:04 ESTNewsXenon Pharmaceuticals Q1 Earnings PreviewN/A
2022-03-02 08:46 ESTNewsXenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13MN/A
2022-03-02 08:46 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-19 20:02 ESTNewsXenon draws buyout speculation after Zogenix dealN/A
2022-01-12 13:22 ESTNewsXenon passes regulatory mark to receive $15M from Neurocrine BiosciencesN/A
2021-12-14 04:59 ESTNewsSizing Up Xenon PharmaceuticalsN/A
2021-12-11 00:58 ESTNewsXenon Pharmaceuticals (XENE) Presents At AES 2021 SymposiumN/A
2021-12-08 15:45 ESTNewsXenon Pharmaceuticals jumps 5% on insider buying worth $100KN/A
2021-12-07 00:52 ESTNewsXenon Pharmaceuticals (XENE) Investor Presentation - SlideshowN/A
2021-12-03 23:16 ESTNewsXenon Pharma presents additional positive data from Phase 2b X-TOLE trial at AES 2021N/A
2021-11-11 15:47 ESTNewsXenon Pharmaceuticals' (XENE) CEO Ian Mortimer on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsXenon Pharma EPS beats by $0.01, misses on revenueN/A
2021-11-09 19:56 ESTNewsXenon Pharma Q3 2021 Earnings PreviewN/A
2021-10-06 21:06 ESTNewsXenon Pharma secures $300M capital raise via equity offeringN/A
2021-10-05 18:52 ESTNewsXenon Pharmaceuticals rises ~4% amid launch of $250M stock offeringN/A
2021-10-04 16:06 ESTNewsXenon Pharma stock jumps 80% on positive XEN1101 data in mid-stage focal epilepsy studyN/A
2021-09-08 18:36 ESTNewsXenon Pharmaceuticals gets $10M milestone payment from Neurocrine collaborationN/A
2021-08-23 17:59 ESTNewsNew medical chief at Xenon PharmaN/A
2021-08-12 06:35 ESTNewsXenon Pharma EPS misses by $0.03, misses on revenueN/A
2021-08-12 06:34 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 09:06 ESTNewsXenon completes patient randomization in mid-stage XEN1101 epilepsy trialN/A
2021-03-10 02:08 ESTNewsXenon Pharmaceuticals readies stock offeringN/A
2021-03-10 02:08 ESTNewsXenon Pharma secures $100M via equity raiseN/A
2021-03-09 06:58 ESTNewsXenon strikes research deal for major depressive disorder treatment XEN1101N/A
2021-03-04 12:48 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $25.29.Buy

About Xenon Pharmaceuticals Inc (XENE):

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment of KCNQ2 epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel modulator, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop FX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.

XENE Quotes by TradingView

See Advanced Chart

General

  • Name Xenon Pharmaceuticals Inc
  • Symbol XENE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 123
  • Fiscal Year EndDecember
  • IPO Date2014-11-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.xenon-pharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 20.81
  • Price/Book (Most Recent Quarter) 4.24
  • Enterprise Value Revenue 16.42
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Next Quarter EPS Estimate -$0.45
  • Profit Margin -90%
  • Operating Margin -97%
  • Return on Assets -12%
  • Return on Equity -22%
  • Revenue 32.17 million
  • Earnings Per Share -$1.72
  • Revenue Per Share $0.93
  • Gross Profit -18357000
  • Quarterly Earnings Growth 54.7%
View More

Highlights

  • Market Capitalization 658.17 million
  • EBITDA -44423000
  • PE Ratio -20.13
  • PEG Ratio -0.06
  • Analyst Target Price $25.29
  • Book Value Per Share $4.67
View More

Share Statistics

  • Shares Outstanding 35.81 million
  • Shares Float 23.33 million
  • % Held by Insiders 658%
  • % Held by Institutions 81.3%
  • Shares Short 943938
  • Shares Short Prior Month 977125
  • Short Ratio 5.34
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.42
  • 52 Week High $21.94
  • 52 Week Low $8.95
  • 50 Day Moving Average 17.43
  • 200 Day Moving Average 13.52
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Xenon Pharmaceuticals Inc (XENE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Xenon Pharmaceuticals Inc (XENE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$5.15 million-$0.34-$0.4015%
2020-09-302020-11-05$N/A-$0.25-$0.17-47.06%
2020-06-302020-08-06$N/A$-0.00-$0.2097.52%
2020-03-312020-05-21$7.08 million-$0.22-$0.3129.6%
2019-12-312020-03-09$3.33 million-$0.41$0.12-441.67%
2019-09-302019-11-05$3.5 million-$0.33-$0.4628.26%
2019-06-302019-08-06$N/A-$0.37-$0.4518.38%
2019-03-312019-05-07$N/A-$0.42-$0.37-13.51%
2018-12-312019-03-06$N/A-$0.29-$0.3619.44%
2018-09-302018-11-06$N/A-$0.63-$0.40-57.5%
2018-06-302018-08-07$N/A-$0.45-$0.498.16%
2018-03-312018-05-08$N/A-$0.46-$0.484.96%
2017-12-312018-03-07$16000-$0.45-$0.44-2.27%
2017-09-302017-11-07$264000-$0.43-$0.39-10.26%
2017-06-302017-08-03$15000-$0.41-$0.39-6.03%
2017-03-312017-05-09$16000-$0.42-$0.38-9.57%
2016-12-312017-03-08$376000-$0.32-$0.4223.21%
2016-09-302016-11-03$413000-$0.51-$0.44-15.25%
2016-06-302016-08-03$413000-$0.42-$0.5016%
2016-03-312016-05-10$601000-$0.23-$0.21-9.52%
2015-12-312016-03-08$3.23 million-$0.27-$0.26-3.85%
2015-09-302015-11-10$4.29 million-$0.27-$0.01-2600%
2015-06-302015-08-10$4.05 million$0.08-$0.15153.33%
2015-03-312015-05-12$4.01 million-$0.30$0.14-314.29%
2014-12-312015-03-12$4.88 million$2.54-$0.0125500%
2014-09-302014-12-15$13.19 million$1.69

Xenon Pharmaceuticals Inc (XENE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Xenon Pharmaceuticals Inc (XENE) Chart:

Xenon Pharmaceuticals Inc (XENE) News:

Below you will find a list of latest news for Xenon Pharmaceuticals Inc (XENE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Xenon Pharmaceuticals Inc (XENE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17200CALL0 0271.91TRUE00
2024-05-1722.50CALL0 0229.42TRUE00
2024-05-17250CALL0 0229.94TRUE00
2024-05-1727.50CALL0 0189.59TRUE00
2024-05-17300CALL0 0160.25TRUE00
2024-05-1732.50CALL0 0135.86TRUE00
2024-05-17350CALL0 0109.36TRUE00
2024-05-1737.50CALL0 085.89TRUE00
2024-05-17401.8CALL0 477.74TRUE00
2024-05-1742.51.5CALL0 2347.65TRUE00
2024-05-17450.65CALL0 77570.24FALSE00
2024-05-1747.50.35CALL0 1196.74FALSE00
2024-05-17500.75CALL0 183.68FALSE00
2024-05-1752.50CALL0 00FALSE00
2024-05-17550.38CALL0 00FALSE00
2024-05-17600CALL0 00FALSE00
2024-05-17650CALL0 00FALSE00
2024-05-17200PUT0 00FALSE00
2024-05-1722.50PUT0 00FALSE00
2024-05-17250PUT0 00FALSE00
2024-05-1727.50PUT0 00FALSE00
2024-05-17300.35PUT0 120FALSE00
2024-05-1732.50PUT0 00FALSE00
2024-05-17350.52PUT0 40FALSE00
2024-05-1737.50PUT0 0111.88FALSE00
2024-05-17401.2PUT0 778.74FALSE00
2024-05-1742.53.9PUT0 13561.48FALSE00
2024-05-17450PUT0 064.29TRUE00
2024-05-1747.50PUT0 084.6TRUE00
2024-05-17500PUT0 091.11TRUE00
2024-05-1752.50PUT0 0107.67TRUE00
2024-05-17550PUT0 0124.86TRUE00
2024-05-17600PUT0 0153.86TRUE00
2024-05-17650PUT0 0177.15TRUE00
2024-06-21150CALL0 0196.33TRUE00
2024-06-2117.50CALL0 0179.9TRUE00
2024-06-21200CALL0 0152.43TRUE00
2024-06-2122.50CALL0 0131.43TRUE00
2024-06-21250CALL0 0115.27TRUE00
2024-06-2127.50CALL0 098.11TRUE00
2024-06-21300CALL0 082.36TRUE00
2024-06-2132.50CALL0 079.21TRUE00
2024-06-21350CALL0 066.71TRUE00
2024-06-2137.53.9CALL0 162.68TRUE00
2024-06-214010.48CALL0 150.1TRUE00
2024-06-2142.54.4CALL0 846.66TRUE00
2024-06-21452.15CALL0 445.46FALSE00
2024-06-2147.50CALL0 048.78FALSE00
2024-06-21500CALL0 055.48FALSE00
2024-06-2152.50.75CALL0 2563.33FALSE00
2024-06-21553.5CALL0 3288.15FALSE00
2024-06-21600.5CALL0 30FALSE00
2024-06-21651.84CALL0 10FALSE00
2024-06-21700CALL0 00FALSE00
2024-06-21150PUT0 00FALSE00
2024-06-2117.50PUT0 00FALSE00
2024-06-21200PUT0 00FALSE00
2024-06-2122.50.05PUT0 110FALSE00
2024-06-21250PUT0 00FALSE00
2024-06-2127.50PUT0 00FALSE00
2024-06-21300PUT0 00FALSE00
2024-06-2132.50PUT0 076.42FALSE00
2024-06-21350PUT0 071.81FALSE00
2024-06-2137.51.75PUT0 5258.26FALSE00
2024-06-21401.65PUT0 9559.63FALSE00
2024-06-2142.54.3PUT0 843.25FALSE00
2024-06-21454.2PUT0 747.76TRUE00
2024-06-2147.50PUT0 052.13TRUE00
2024-06-21500PUT0 055.81TRUE00
2024-06-2152.50PUT0 061.07TRUE00
2024-06-21550PUT0 069.45TRUE00
2024-06-21600PUT0 084.28TRUE00
2024-06-21650PUT0 0101.07TRUE00
2024-06-21700PUT0 096.25TRUE00
2024-07-1917.50CALL0 0105.25TRUE00
2024-07-19200CALL0 0120.45TRUE00
2024-07-1922.50CALL0 0105.7TRUE00
2024-07-19250CALL0 088.19TRUE00
2024-07-1927.50CALL0 068.02TRUE00
2024-07-19300CALL0 075.92TRUE00
2024-07-1932.50CALL0 062.97TRUE00
2024-07-19350CALL0 059.06TRUE00
2024-07-1937.53.5CALL0 148.13TRUE00
2024-07-19402.8CALL0 349.29TRUE00
2024-07-1942.50CALL0 044.48TRUE00
2024-07-19454.5CALL0 1043.64FALSE00
2024-07-1947.50CALL0 040.9FALSE00
2024-07-19506.28CALL0 1160.27FALSE00
2024-07-1952.50CALL0 050.71FALSE00
2024-07-19550CALL0 057.02FALSE00
2024-07-19602.2CALL0 5660FALSE00
2024-07-19650.35CALL0 500FALSE00
2024-07-19700.7CALL0 10FALSE00
2024-07-1917.50PUT0 00FALSE00
2024-07-19200PUT0 00FALSE00
2024-07-1922.50PUT0 00FALSE00
2024-07-19250PUT0 00FALSE00
2024-07-1927.50PUT0 00FALSE00
2024-07-19300PUT0 00FALSE00
2024-07-1932.50PUT0 060.27FALSE00
2024-07-19351.95PUT0 162.76FALSE00
2024-07-1937.51.55PUT0 157.53FALSE00
2024-07-19402.85PUT0 65455.8FALSE00
2024-07-1942.52.6PUT0 352.62FALSE00
2024-07-19450PUT0 048.22TRUE00
2024-07-1947.50PUT0 049.11TRUE00
2024-07-19500PUT0 051.45TRUE00
2024-07-1952.50PUT0 051.53TRUE00
2024-07-19550PUT0 055.71TRUE00
2024-07-19600PUT0 059.95TRUE00
2024-07-19650PUT0 080.37TRUE00
2024-07-19700PUT0 089.85TRUE00
2024-10-18200CALL0 087.34TRUE00
2024-10-1822.50CALL0 071.23TRUE00
2024-10-18250CALL0 064.27TRUE00
2024-10-1827.50CALL0 060.83TRUE00
2024-10-18300CALL0 056.45TRUE00
2024-10-1832.50CALL0 046.01TRUE00
2024-10-18350CALL0 042.71TRUE00
2024-10-1837.50CALL0 041.73TRUE00
2024-10-18400CALL0 048.17TRUE00
2024-10-1842.50CALL0 043.79TRUE00
2024-10-18450CALL0 045.52FALSE00
2024-10-1847.50CALL0 041.41FALSE00
2024-10-18502.7CALL0 146.36FALSE00
2024-10-1852.50CALL0 043.69FALSE00
2024-10-18550CALL0 050.44FALSE00
2024-10-1857.50CALL0 055.08FALSE00
2024-10-18600CALL0 043.17FALSE00
2024-10-18650.55CALL0 253.92FALSE00
2024-10-18700CALL0 054.85FALSE00
2024-10-18200PUT0 00FALSE00
2024-10-1822.50PUT0 00FALSE00
2024-10-18250PUT0 00FALSE00
2024-10-1827.50PUT0 087.84FALSE00
2024-10-18300PUT0 063.13FALSE00
2024-10-1832.50PUT0 056.59FALSE00
2024-10-18350PUT0 057.64FALSE00
2024-10-1837.50PUT0 049.41FALSE00
2024-10-18400PUT0 050.08FALSE00
2024-10-1842.50PUT0 050.57FALSE00
2024-10-18450PUT0 049.3TRUE00
2024-10-1847.50PUT0 049.67TRUE00
2024-10-18500PUT0 047.79TRUE00
2024-10-1852.50PUT0 050.16TRUE00
2024-10-18550PUT0 050.58TRUE00
2024-10-1857.50PUT0 051.11TRUE00
2024-10-18600PUT0 054.92TRUE00
2024-10-18650PUT0 059.6TRUE00
2024-10-18700PUT0 061.2TRUE00
2024-12-20150CALL0 0144.58TRUE00
2024-12-2017.514.84CALL0 1059.02TRUE00
2024-12-20200CALL0 068.23TRUE00
2024-12-2022.50CALL0 066.6TRUE00
2024-12-202525.5CALL0 258.36TRUE00
2024-12-2027.50CALL0 055.39TRUE00
2024-12-20300CALL0 051.64TRUE00
2024-12-2032.50CALL0 046.77TRUE00
2024-12-20359.5CALL0 145.4TRUE00
2024-12-2037.50CALL0 042.86TRUE00
2024-12-204012.17CALL0 541.07TRUE00
2024-12-2042.50CALL0 045.48TRUE00
2024-12-20450CALL0 043.48FALSE00
2024-12-2047.50CALL0 049.99FALSE00
2024-12-20503.97CALL0 3444.88FALSE00
2024-12-2052.50CALL0 042.65FALSE00
2024-12-20557.04CALL0 2545.59FALSE00
2024-12-20600CALL0 050.25FALSE00
2024-12-20650CALL0 048.91FALSE00
2024-12-20700CALL0 050.62FALSE00
2024-12-20150PUT0 00FALSE00
2024-12-2017.50PUT0 00FALSE00
2024-12-20201.08PUT0 30FALSE00
2024-12-2022.50PUT0 075.94FALSE00
2024-12-20250PUT0 086.38FALSE00
2024-12-2027.50PUT0 075.82FALSE00
2024-12-20300PUT0 067.04FALSE00
2024-12-2032.50PUT0 057.94FALSE00
2024-12-20356PUT0 25456.96FALSE00
2024-12-2037.50PUT0 047.82FALSE00
2024-12-20403PUT0 349.9FALSE00
2024-12-2042.50PUT0 047.79FALSE00
2024-12-20450PUT0 048.97TRUE00
2024-12-2047.50PUT0 048.68TRUE00
2024-12-20500PUT0 048.51TRUE00
2024-12-2052.50PUT0 047.37TRUE00
2024-12-20550PUT0 049.35TRUE00
2024-12-20600PUT0 048.58TRUE00
2024-12-20650PUT0 051.05TRUE00
2024-12-20700PUT0 061.86TRUE00
2025-01-17200CALL0 071.09TRUE00
2025-01-1722.50CALL0 064.58TRUE00
2025-01-17250CALL0 060.28TRUE00
2025-01-1727.50CALL0 055.68TRUE00
2025-01-17300CALL0 050.22TRUE00
2025-01-1732.50CALL0 049.92TRUE00
2025-01-17350CALL0 050.18TRUE00
2025-01-1737.50CALL0 050.36TRUE00
2025-01-17407CALL0 050.14TRUE00
2025-01-1742.50CALL0 047.82TRUE00
2025-01-17450CALL0 046.84FALSE00
2025-01-1747.50CALL0 046.39FALSE00
2025-01-17505CALL0 146.13FALSE00
2025-01-1752.50CALL0 047.75FALSE00
2025-01-17550CALL0 047.11FALSE00
2025-01-17600CALL0 048.52FALSE00
2025-01-17650CALL0 045.89FALSE00
2025-01-17702.5CALL0 257.73FALSE00
2025-01-17200PUT0 00FALSE00
2025-01-1722.50PUT0 00FALSE00
2025-01-17250PUT0 00FALSE00
2025-01-1727.50PUT0 071.98FALSE00
2025-01-17300PUT0 056.64FALSE00
2025-01-1732.50PUT0 054.85FALSE00
2025-01-17350PUT0 048.88FALSE00
2025-01-1737.50PUT0 049.16FALSE00
2025-01-17400PUT0 048.18FALSE00
2025-01-1742.50PUT0 049.28FALSE00
2025-01-17450PUT0 050.34TRUE00
2025-01-1747.50PUT0 050.44TRUE00
2025-01-17500PUT0 048.27TRUE00
2025-01-1752.50PUT0 048.07TRUE00
2025-01-17550PUT0 052.37TRUE00
2025-01-17600PUT0 052.65TRUE00
2025-01-17650PUT0 053.53TRUE00
2025-01-17700PUT0 055.08TRUE00

Latest XENE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$27.26
Jun 13, 2022 7:59 PM EST89$27.26
Jun 13, 2022 7:59 PM EST5$27.24
Jun 13, 2022 7:59 PM EST3$27.24
Jun 13, 2022 7:59 PM EST26$27.24

Xenon Pharmaceuticals Inc (XENE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520001824/0000921895-20-001824-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1582313/000000000019012321/0000000000-19-012321-index.htm
2020-06-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1582313/000000000020005143/0000000000-20-005143-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000085874419000023/0000858744-19-000023-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924318030608/0000899243-18-030608-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319007264/0000899243-19-007264-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319008569/0000899243-19-008569-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319014470/0000899243-19-014470-index.htm
2018-07-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266418002713/0000902664-18-002713-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266419000946/0000902664-19-000946-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266419001016/0000902664-19-001016-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266420000959/0000902664-20-000959-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189519000466/0000921895-19-000466-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520000548/0000921895-20-000548-index.htm
2020-06-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520001824/0000921895-20-001824-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004459/0001171843-18-004459-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004460/0001171843-18-004460-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004461/0001171843-18-004461-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004695/0001171843-18-004695-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004795/0001171843-18-004795-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/0001171843-18-008430-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008471/0001171843-18-008471-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008556/0001171843-18-008556-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049538/0001209191-19-049538-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049864/0001209191-19-049864-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050127/0001209191-19-050127-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050129/0001209191-19-050129-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050131/0001209191-19-050131-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050133/0001209191-19-050133-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050143/0001209191-19-050143-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050146/0001209191-19-050146-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050164/0001209191-19-050164-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050166/0001209191-19-050166-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050169/0001209191-19-050169-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050172/0001209191-19-050172-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050588/0001209191-19-050588-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119059515/0001209191-19-059515-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119060910/0001209191-19-060910-index.htm
2020-01-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120003271/0001209191-20-003271-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120003273/0001209191-20-003273-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018941/0001209191-20-018941-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018951/0001209191-20-018951-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018958/0001209191-20-018958-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018963/0001209191-20-018963-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018969/0001209191-20-018969-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120032628/0001209191-20-032628-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033588/0001209191-20-033588-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033593/0001209191-20-033593-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033596/0001209191-20-033596-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033605/0001209191-20-033605-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033627/0001209191-20-033627-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033639/0001209191-20-033639-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033643/0001209191-20-033643-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033653/0001209191-20-033653-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033669/0001209191-20-033669-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120035608/0001209191-20-035608-index.htm
2020-08-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120046970/0001209191-20-046970-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120046974/0001209191-20-046974-index.htm
2020-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120048095/0001209191-20-048095-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120056222/0001209191-20-056222-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2020-11-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120057205/0001209191-20-057205-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120057208/0001209191-20-057208-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000121390020003603/0001213900-20-003603-index.htm
2018-06-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000142284918000162/0001422849-18-000162-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000142284918000178/0001422849-18-000178-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018015497/0001564590-18-015497-index.htm
2018-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018016554/0001564590-18-016554-index.htm
2018-07-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018016768/0001564590-18-016768-index.htm
2018-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018016771/0001564590-18-016771-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018020000/0001564590-18-020000-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018020005/0001564590-18-020005-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018020018/0001564590-18-020018-index.htm
2018-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022422/0001564590-18-022422-index.htm
2018-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022703/0001564590-18-022703-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022911/0001564590-18-022911-index.htm
2018-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018023027/0001564590-18-023027-index.htm
2018-09-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018023031/0001564590-18-023031-index.htm
2018-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018023099/0001564590-18-023099-index.htm
2018-09-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018023102/0001564590-18-023102-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018027409/0001564590-18-027409-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018027475/0001564590-18-027475-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019006512/0001564590-19-006512-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1582313/000156459019006514/0001564590-19-006514-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019006522/0001564590-19-006522-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019007593/0001564590-19-007593-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019009156/0001564590-19-009156-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019013752/0001564590-19-013752-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019016573/0001564590-19-016573-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019016580/0001564590-19-016580-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019021713/0001564590-19-021713-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019029412/0001564590-19-029412-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019029418/0001564590-19-029418-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1582313/000156459019029440/0001564590-19-029440-index.htm
2019-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1582313/000156459019031813/0001564590-19-031813-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019034466/0001564590-19-034466-index.htm
2019-09-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019034720/0001564590-19-034720-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019040445/0001564590-19-040445-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019040449/0001564590-19-040449-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019040458/0001564590-19-040458-index.htm
2019-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019040484/0001564590-19-040484-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019044971/0001564590-19-044971-index.htm
2019-12-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1582313/000156459019045741/0001564590-19-045741-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020000685/0001564590-20-000685-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020000901/0001564590-20-000901-index.htm
2020-01-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020001642/0001564590-20-001642-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020001789/0001564590-20-001789-index.htm
2020-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020001790/0001564590-20-001790-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020009357/0001564590-20-009357-index.htm
2020-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1582313/000156459020009385/0001564590-20-009385-index.htm
2020-03-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020009391/0001564590-20-009391-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020010133/0001564590-20-010133-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020010811/0001564590-20-010811-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020019198/0001564590-20-019198-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020021912/0001564590-20-021912-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020026545/0001564590-20-026545-index.htm
2020-05-2110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026574/0001564590-20-026574-index.htm
2020-05-2210-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026739/0001564590-20-026739-index.htm
2020-05-2610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026807/0001564590-20-026807-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028137/0001564590-20-028137-index.htm
2020-06-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028139/0001564590-20-028139-index.htm
2020-06-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1582313/000156459020028142/0001564590-20-028142-index.htm
2020-06-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028884/0001564590-20-028884-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020037751/0001564590-20-037751-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020037862/0001564590-20-037862-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020037867/0001564590-20-037867-index.htm
2020-08-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020037893/0001564590-20-037893-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020040375/0001564590-20-040375-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020051310/0001564590-20-051310-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020051443/0001564590-20-051443-index.htm
2018-07-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000161577418006468/0001615774-18-006468-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000161577419002513/0001615774-19-002513-index.htm
2019-08-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1582313/999999999519001895/9999999995-19-001895-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1582313/999999999520001418/9999999995-20-001418-index.htm
2018-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999718007811/9999999997-18-007811-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999718009592/9999999997-18-009592-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999719006777/9999999997-19-006777-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999719006778/9999999997-19-006778-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1582313/999999999720000547/9999999997-20-000547-index.htm
2020-02-27SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1582313/999999999720001048/9999999997-20-001048-index.htm
2020-09-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999720004559/9999999997-20-004559-index.htm

Xenon Pharmaceuticals Inc (XENE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xenon Pharmaceuticals Inc (XENE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 658%
Institutional Ownership: 8130%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-20FRANK A HOLLERDirectorSell5,206.009.3948,884.34118,955.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-12SHERRINGTON ROBINEVP, Strategy & InnovationBuy6,172.003.0718,948.0412,064.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049538/0001209191-19-049538-index.htm
2019-09-12FRANK A HOLLERDirectorBuy3,086.003.7011,418.20122,041.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2020-05-29FRANK A HOLLERDirectorBuy3,086.003.5610,986.16122,041.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033588/0001209191-20-033588-index.htm
2019-09-19FRANK A HOLLERDirectorSell7,600.009.2770,452.00124,161.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-12FRANK A HOLLERDirectorBuy3,086.003.079,474.02124,193.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2019-09-18FRANK A HOLLERDirectorSell4,368.009.2840,535.04131,761.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-17FRANK A HOLLERDirectorSell5,069.009.3247,243.08136,129.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-12FRANK A HOLLERDirectorBuy25,720.003.0077,160.00148,979.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2020-06-01SHERRINGTON ROBINEVP, Strategy & InnovationBuy8,230.003.5629,298.8018,426.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033669/0001209191-20-033669-index.htm
2018-12-14GARY PATOUDirectorBuy2,057.003.076,314.9919,459.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318008471/0001171843-18-008471-index.htm
2018-06-14GARY PATOUDirectorBuy8,230.003.7030,451.0020,258.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004695/0001171843-18-004695-index.htm
2019-12-04GARY PATOUDirectorBuy2,057.003.567,322.9221,516.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119059515/0001209191-19-059515-index.htm
2020-10-28GARY PATOUDirectorBuy2,057.003.767,734.3223,573.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056222/0001209191-20-056222-index.htm
2020-06-01SIMON N. PIMSTONECEOSell3,000.0014.4343,290.00255,186.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2019-09-20SIMON N. PIMSTONECEOSell10,395.009.5198,856.45258,122.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050588/0001209191-19-050588-index.htm
2020-05-29SIMON N. PIMSTONECEOSell5,000.0013.9969,950.00258,186.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy9,259.003.0728,425.13262,633.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy36,008.003.70133,229.60264,143.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2020-05-26SIMON N. PIMSTONECEOBuy6,172.003.5621,972.32264,294.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120032628/0001209191-20-032628-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy12,345.003.3841,726.10272,209.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-03-19Michael R HaydenDirectorBuy20,576.003.3869,546.8850,924.00https://www.sec.gov/Archives/edgar/data/1582313/000089924319008569/0000899243-19-008569-index.htm
2018-06-21MOHAMMAD AZABDirectorBuy10,288.003.7038,065.6054,498.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004795/0001171843-18-004795-index.htm
2019-09-13MOHAMMAD AZABDirectorSell23.009.31214.1857,561.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049864/0001209191-19-049864-index.htm
2018-12-06MOHAMMAD AZABDirectorBuy3,086.003.079,474.0257,584.00https://www.sec.gov/Archives/edgar/data/1582313/000089924318030608/0000899243-18-030608-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy5,144.003.7019,032.8060,311.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-12-16MOHAMMAD AZABDirectorBuy3,086.003.5610,986.1660,647.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119060910/0001209191-19-060910-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy2,057.003.667,528.6262,368.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-05-21MICHAEL M TARNOWDirectorBuy2,057.003.216,602.9764,569.00https://www.sec.gov/Archives/edgar/data/1582313/000089924319014470/0000899243-19-014470-index.htm
2019-11-21MICHAEL M TARNOWDirectorBuy2,057.003.517,220.0766,626.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy5,144.003.0715,792.0867,512.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-11-21MICHAEL M TARNOWDirectorBuy5,144.003.5618,312.6469,713.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2020-06-09MICHAEL M TARNOWDirectorBuy5,144.003.5218,106.8869,713.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120035608/0001209191-20-035608-index.htm
2020-10-28MICHAEL M TARNOWDirectorBuy5,144.003.7619,341.4474,857.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2020-10-28MICHAEL M TARNOWDirectorBuy5,144.003.7619,341.4480,001.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2018-12-11CHARLES J. COHENVP, BiologyBuy4,115.003.0712,633.058,194.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/0001171843-18-008430-index.htm